Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koki Aoki

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Nippon Ganka Gakkai Zasshi|December 10, 2009
[Pathogenesis of infectious conjunctivitis in Nepal]Takeshi Naito, Koki Aoki, Takeshi Ohguchi, et al.
European Journal of Ophthalmology|December 10, 2019
Disinfectant potential in inactivation of epidemic keratoconjunctivitis-related adenoviruses by potassium peroxymonosulfateMei Hashizume, Koki Aoki, Shigeaki Ohno, et al.
Journal of Clinical Microbiology|April 4, 2008
Novel human adenovirus causing nosocomial epidemic keratoconjunctivitisHiroaki Ishiko, Yasushi Shimada, Tsunetada Konno, et al.
Antiviral Research|December 13, 2003
The cotton rat model for adenovirus ocular infection: antiviral activity of cidofovirHisatoshi Kaneko, Shuichi Mori, Osamu Suzuki, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|August 31, 2007
Antiadenoviral effect of the alpha 5 beta 1 integrin receptor ligand, GRGDSP peptide, in serotypes that cause acute keratoconjunctivitisEiichi Uchio, Ryoji Kimura, Yuh-Huey Huang, et al.
Journal of Clinical Microbiology|August 15, 2008
Epidemic keratoconjunctivitis due to the novel hexon-chimeric-intermediate 22,37/H8 human adenovirusKoki Aoki, Hiroaki Ishiko, Tsunetada Konno, et al.
Journal of Virology|April 1, 2011
Toward an integrated human adenovirus designation system that utilizes molecular and serological data and serves both clinical and fundamental virologyKoki Aoki, Mária Benkö, Andrew J Davison, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 29, 2005
Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis--a double-blind, randomized, phase-2 clinical trialBarbara Teuchner, Markus Nagl, Axel Schidlbauer, et al.
Nippon Ganka Gakkai Zasshi|September 17, 2005
[Clinical and virological studies of nosocomial conjunctivitis infection caused by adenovirus type 37 variant]Hisatoshi Kaneko, Takeshi Kondo, Toshiyuki Fujiwara, et al.
Journal of Clinical Microbiology|December 15, 2010
Complete genome analysis of a novel intertypic recombinant human adenovirus causing epidemic keratoconjunctivitis in JapanHisatoshi Kaneko, Koki Aoki, Shigeaki Ohno, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Nippon Ganka Gakkai Zasshi|December 10, 2009
[Pathogenesis of infectious conjunctivitis in Nepal]Takeshi Naito, Koki Aoki, Takeshi Ohguchi, et al.
European Journal of Ophthalmology|December 10, 2019
Disinfectant potential in inactivation of epidemic keratoconjunctivitis-related adenoviruses by potassium peroxymonosulfateMei Hashizume, Koki Aoki, Shigeaki Ohno, et al.
Journal of Clinical Microbiology|April 4, 2008
Novel human adenovirus causing nosocomial epidemic keratoconjunctivitisHiroaki Ishiko, Yasushi Shimada, Tsunetada Konno, et al.
Antiviral Research|December 13, 2003
The cotton rat model for adenovirus ocular infection: antiviral activity of cidofovirHisatoshi Kaneko, Shuichi Mori, Osamu Suzuki, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|August 31, 2007
Antiadenoviral effect of the alpha 5 beta 1 integrin receptor ligand, GRGDSP peptide, in serotypes that cause acute keratoconjunctivitisEiichi Uchio, Ryoji Kimura, Yuh-Huey Huang, et al.
Journal of Clinical Microbiology|August 15, 2008
Epidemic keratoconjunctivitis due to the novel hexon-chimeric-intermediate 22,37/H8 human adenovirusKoki Aoki, Hiroaki Ishiko, Tsunetada Konno, et al.
Journal of Virology|April 1, 2011
Toward an integrated human adenovirus designation system that utilizes molecular and serological data and serves both clinical and fundamental virologyKoki Aoki, Mária Benkö, Andrew J Davison, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 29, 2005
Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis--a double-blind, randomized, phase-2 clinical trialBarbara Teuchner, Markus Nagl, Axel Schidlbauer, et al.
Nippon Ganka Gakkai Zasshi|September 17, 2005
[Clinical and virological studies of nosocomial conjunctivitis infection caused by adenovirus type 37 variant]Hisatoshi Kaneko, Takeshi Kondo, Toshiyuki Fujiwara, et al.
Journal of Clinical Microbiology|December 15, 2010
Complete genome analysis of a novel intertypic recombinant human adenovirus causing epidemic keratoconjunctivitis in JapanHisatoshi Kaneko, Koki Aoki, Shigeaki Ohno, et al.
Pageof 5